This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. BD has expanded a Class I Alaris recall to cover 15 ...

A vulnerability found in software used to monitor some of BD’s infusion pumps could potentially give hackers access to personal data stored in the system. BD posted a cybersecurity bulletin about the ...

Medtronic ($MDT) will commercialize Becton Dickinson's ($BDX) insulin pump infusion set with FlowSmart technology, the companies announced at the annual meeting of ...

Becton, Dickinson and Company BDX, popularly known as BD, recently received the FDA’s 510(k) clearance for its updated BD Alaris Infusion System. This is expected to enable both remediation and a ...

BD and federal regulators have issued security warnings about the company's Alaris Gateway Workstation. Medical device vendor Becton Dickinson and U.S. federal regulators have issued security alerts ...

Infusion pumps are the most common connected medical devices in hospitals and "possess the lion's share" of cybersecurity risk, concluded Cynerio's January report. The Palo Alto Networks study, ...

The FDA approved BD's (Becton, Dickinson, and Company) (NYSE:BDX) BD Alaris Infusion System with 510(k) clearance, which enables both remediation and a return to full commercial operations for the ...

FRANKLIN LAKES, N.J., Nov. 13, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company (BDX)), a leading global medical technology company, today announced that Duncan Regional Hospital ("DRH Health") ...

FILE PHOTO: Signage is seen outside of FDA headquarters in White Oak, Maryland (Reuters) -The U.S. Food and Drug Administration (FDA) said on Friday that Becton Dickinson is recalling its Alaris ...

BD (Becton, Dickinson and Company), a leading global medical technology company, announced that the updated BD Alaris Infusion System has received 510(k) clearance from the US Food and Drug ...

BD (Becton, Dickinson and Company), a leading global medical technology company, announces the approval of the BD Saf-T-Intima™ Safety Integrated IV Catheter System for use in subcutaneous infusion ...

Please provide your email address to receive an email when new articles are posted on . BD will be entering into a new research partnership with JDRF to improve insulin infusion sets, according to a ...